Infusion therapy for chronic liver diseases

Aim of review. To present modern options of comprehensive infusion therapy at various liver diseases, indications and contraindications for application of basic blood substitute groups, and pathogenically justified approaches for their use. Summary. Chronic and acute liver diseases are associated to...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Kurkina, M. V. Mayevskaya, I. N. Tikhonov, V. N. Zozulya, V. I. Leschenko
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/243
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860316205744128
author I. A. Kurkina
M. V. Mayevskaya
I. N. Tikhonov
V. N. Zozulya
V. I. Leschenko
author_facet I. A. Kurkina
M. V. Mayevskaya
I. N. Tikhonov
V. N. Zozulya
V. I. Leschenko
author_sort I. A. Kurkina
collection DOAJ
description Aim of review. To present modern options of comprehensive infusion therapy at various liver diseases, indications and contraindications for application of basic blood substitute groups, and pathogenically justified approaches for their use. Summary. Chronic and acute liver diseases are associated to end the genius intoxication, electrolyte disorders, shift of acid-base state, tissue and cellular hypoxia. Infusion therapy with application of modern plasma substitute solutions provide increase in treatment efficacy for this group of patients. Application of basic group infusion solutions along with complex anti-hypoxia agents helps to correct water and electrolyte imbalance as well as disorders of acid-base state, carry out body detoxication, normalize blood pressure, treat edema and ascites syndrome, protein-energy malnutrition, prevent renal value and other complications in liver cirrhosis patients. Comprehensive treatment of liver diseases includes application of modern infusion agents (anti-hypoxia/anti-oxidation) containing pharmacologically active metabolic substances that include succinate-containing drugs developed on the basis of succinic acid and its salts. Succinic acid is presumed to act as the paracrine agent produced by damage hepatocytes (e.g. at ischemia), affecting pericytes (Ito's cell) in the liver through SUCNR1receptors. It results activation of pericytes providing synthesis of extracellular matrix components that are involved in metabolism and regeneration of liver parenchyma cells. Conclusion. Addition of succinic acid-based medications to infusion therapy program for chronic liver diseases provides alleviation of basic clinical syndromes (intoxication, asthenic and autonomous nervous disorders, dyspeptic, cholestatic), and at patients with hepatocellular failure improvement of protein-synthetic liver function.
format Article
id doaj-art-e898c4466b08491aaa703044cd181c90
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-e898c4466b08491aaa703044cd181c902025-02-10T16:14:29ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01283818710.22416/1382-4376-2018-28-3-81-87243Infusion therapy for chronic liver diseasesI. A. Kurkina0M. V. Mayevskaya1I. N. Tikhonov2V. N. Zozulya3V. I. Leschenko4Sechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversitySechenov First Moscow State Medical UniversityAim of review. To present modern options of comprehensive infusion therapy at various liver diseases, indications and contraindications for application of basic blood substitute groups, and pathogenically justified approaches for their use. Summary. Chronic and acute liver diseases are associated to end the genius intoxication, electrolyte disorders, shift of acid-base state, tissue and cellular hypoxia. Infusion therapy with application of modern plasma substitute solutions provide increase in treatment efficacy for this group of patients. Application of basic group infusion solutions along with complex anti-hypoxia agents helps to correct water and electrolyte imbalance as well as disorders of acid-base state, carry out body detoxication, normalize blood pressure, treat edema and ascites syndrome, protein-energy malnutrition, prevent renal value and other complications in liver cirrhosis patients. Comprehensive treatment of liver diseases includes application of modern infusion agents (anti-hypoxia/anti-oxidation) containing pharmacologically active metabolic substances that include succinate-containing drugs developed on the basis of succinic acid and its salts. Succinic acid is presumed to act as the paracrine agent produced by damage hepatocytes (e.g. at ischemia), affecting pericytes (Ito's cell) in the liver through SUCNR1receptors. It results activation of pericytes providing synthesis of extracellular matrix components that are involved in metabolism and regeneration of liver parenchyma cells. Conclusion. Addition of succinic acid-based medications to infusion therapy program for chronic liver diseases provides alleviation of basic clinical syndromes (intoxication, asthenic and autonomous nervous disorders, dyspeptic, cholestatic), and at patients with hepatocellular failure improvement of protein-synthetic liver function.https://www.gastro-j.ru/jour/article/view/243инфузионная терапиягепатитцирроз печениальбуминянтарная кислота
spellingShingle I. A. Kurkina
M. V. Mayevskaya
I. N. Tikhonov
V. N. Zozulya
V. I. Leschenko
Infusion therapy for chronic liver diseases
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
инфузионная терапия
гепатит
цирроз печени
альбумин
янтарная кислота
title Infusion therapy for chronic liver diseases
title_full Infusion therapy for chronic liver diseases
title_fullStr Infusion therapy for chronic liver diseases
title_full_unstemmed Infusion therapy for chronic liver diseases
title_short Infusion therapy for chronic liver diseases
title_sort infusion therapy for chronic liver diseases
topic инфузионная терапия
гепатит
цирроз печени
альбумин
янтарная кислота
url https://www.gastro-j.ru/jour/article/view/243
work_keys_str_mv AT iakurkina infusiontherapyforchronicliverdiseases
AT mvmayevskaya infusiontherapyforchronicliverdiseases
AT intikhonov infusiontherapyforchronicliverdiseases
AT vnzozulya infusiontherapyforchronicliverdiseases
AT vileschenko infusiontherapyforchronicliverdiseases